Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
1(50.0%)
N/A
1(50.0%)
2Total
Phase 2(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05366907Completed

Open Cholecystectomy Among Patients Undergoing Laparoscopic Cholecystectomy.

Role: lead

NCT04675190Completed

Major Surgery as a Risk of Gall Stone Disease?

Role: collaborator

NCT05506748Completed

Association Between Preoperative HALP and Immediate Postoperative Outcomes

Role: lead

NCT04387487Not ApplicableUnknown

Does Showing Video Information About Spinal Anesthesia Relieves Patient Anxiety?

Role: lead

NCT03200002Phase 2Completed

Cyclophosphamide Versus Mycophenolate Mofetil in Lupus Nephritis

Role: lead

All 5 trials loaded